Revue medicale de Liege 2013-01-01

[Rapid opiate detoxification under anesthesia (RODA)].

N Dubols, C Hallet, D Luppens, M Ansseau, C Charlier

文献索引:Rev. Med. Liege. 68(5-6) , 298-302, (2013)

全文:HTML全文

摘要

Rapid Opiate Detoxification under Anesthesia (RODA) involves the use of opiate antagonists combined with anesthesia and pharmacotherapy to reduce withdrawal symptoms. The aim of our study was to measure the plasma concentrations of heroin metabolites and methadone during anesthesia and patient stay at the hospital in order to assess the amount of active substances at each protocol step. Plasma concentrations of antagonists were also quantified and compared to the recommended target values. Blood samples were drawn in 10 patients undergoing RODA at different times of the procedure (during anesthesia, in post-anesthesia care unit and in psychiatry unit). The plasma concentrations of heroin metabolites, methadone and antagonists were measured using a previously described method. Heroin active metabolites were no longer detected in the patient blood when helshe left the hospital; by contrast, methadone was still present at significant concentrations 3 days after the beginning of the detoxification procedure. Naltrexone analysis allowed us to adjust doses to insure opiate receptor blockade during acute withdrawal, which is a critical period.


相关化合物

  • 盐酸美沙酮
  • 纳曲酮
  • 甲醇:水(1:1)测试标...
  • 吗啡-3-Β-D-葡糖苷...
  • 美沙酮
  • 吗啡
  • 吗啡五水硫酸盐
  • 二水合盐酸纳洛酮
  • 吗啡硫酸盐甲醇

相关文献:

Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.

2014-09-01

[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]

Cyclosporine-inhibitable cerebral drug transport does not influence clinical methadone pharmacodynamics.

2014-12-01

[Anesthesiology 121(6) , 1281-91, (2014)]

Disaccharides in urine samples as markers of intravenous abuse of methadone and buprenorphine.

2013-01-01

[J. Anal. Toxicol. 37(9) , 652-8, (2013)]

[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].

2014-12-01

[Presse Med. 43(12 Pt 1) , 1314-6, (2014)]

Risk reduction with buprenorphine-naloxone and methadone: patient's choice.

2014-12-15

[J. Acquir. Immune Defic. Syndr. 67(5) , e142, (2014)]

更多文献...